Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company's stock, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Chemed Price Performance
Shares of CHE stock opened at $539.13 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $551.68. The firm has a market capitalization of $7.05 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 2.05 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock's 50-day simple moving average is $471.15 and its 200-day simple moving average is $437.76.
Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.
Chemed Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. Chemed's dividend payout ratio is presently 12.05%.
Analysts Set New Price Targets
Several equities research analysts have recently commented on the stock. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday. Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 30th. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Oppenheimer increased their price objective on Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a report on Friday. Finally, Weiss Ratings upgraded Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Chemed has a consensus rating of "Hold" and an average price target of $530.75.
Read Our Latest Analysis on CHE
Institutional Trading of Chemed
Large investors have recently made changes to their positions in the business. Commonwealth Equity Services LLC raised its holdings in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company's stock worth $314,000 after purchasing an additional 22 shares during the last quarter. Cim LLC lifted its position in Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company's stock valued at $958,000 after purchasing an additional 24 shares during the period. Eukles Asset Management boosted its holdings in Chemed by 0.4% in the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company's stock valued at $2,591,000 after purchasing an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company's stock worth $153,000 after purchasing an additional 35 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.
Chemed Company Profile
(
Get Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
